clinical perspectives on her2-targeted antibody-drug conjugates: treatment-related adverse events
Published 5 months ago • 3 plays • Length 37:44Download video MP4
Download video MP3
Similar videos
-
6:30
managing pulmonary and cardiac adverse events related to adc therapy in breast cancer
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
32:57
role of her2-directed therapy in the treatment of her2-expressing gyn cancers (companion lecture)
-
8:17
understanding the potential side effects of herceptin
-
6:40
her2 breast cancer: managing patients on t-dm1
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:07:30
oncology today with dr neil love: role of her2-directed therapy in the treatment of her2-expressing
-
16:00
foundation frontiers: advanced breast cancer - updates to hr /her2- treatment landscape
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
20:17
optimizing her2-positive breast cancer therapy: balancing efficacy and toxicity
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
1:05:22
gynecologic cancers | oncology today with dr neil love: role of her2-directed therapy in the trea...
-
0:35
termination of trastuzumab in her2-positive metastatic breast cancer patients who rec... | rtcl.tv
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
32:30
chairperson perspective: precision payloads: exploring adc-directed therapies in her2-mutant and ...
-
5:00
pivotal data on targeting her2 in her2-expressing solid tumors
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
2:41
dr tarantino on the safety of t-dxd and t-dm1 in her2 breast cancer